Evaluating Stress Response and Anxiety Score in Paediatric Patients
Status:
Completed
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
To date, there have been no studies done relating serum cortisol levels and intranasal
dexmedetomidine sedation. However, there was a behavioral study done on pediatric patients
confirming reduction serum cortisol levels with perioperative dialogue intervention.There
have been a number of studies done on adult patients indicating that dexmedetomidine was
indeed capable of reducing level of anxiety with evidence of lower serum cortisol levels.
Hence, we postulated that intranasal dexmedetomidine administration in pediatric patients
will lower the serum cortisol levels but we need to evaluate the extent of reduction.